Newick, K., Obrien, S., Moon, E., et al. (2017) .CAR-T Cell Therapy for Solid Tumors. Annual Review of Medicine, 68(1): 139-52.[2] Zhao, J., Lin, Q., Song, Y., et al. (2018) .Universal CARs, Universal T Cells, and Universal CAR-T Cells. Hematol Oncol, 11(1):132. [3] Barros, L.R.C. (2021). In Search of an Ideal CAR-T Cell Antigen Target. Crit Rev Immunol, 41(1):69-76. [4] Rodriguez-Garcia, A., Lynn, R.C., Poussin, M., et al. (2021). CAR-T Cell-mediated Depletion of Immunosuppressive Tumor-associated Macrophages Promotes Endogenous Antitumor Immunity and Augments Adoptive Immunotherapy. Nat Commun, 12(1):877.[5] Mehrabadi, A.Z., Ranjbar, R., Farzanehpour, M., et al. (2022). Therapeutic Potential of CAR-T Cell in Malignancies: A Scoping Review. Biomed Pharmacother, 146:112512. [6] Guo, F., Cui, J. (2021). Current Challenges and Optimization Strategies of CAR-T Cell Therapy for Solid Tumors. Chin J. Cancer Clinic, 49(12):617-21.[7] Chen, X. (2009) . Expression and Clinical Significance of Costimulatory Molecules B7-H1, B7-H3 and B7-H4 in Human Pancreatic Cancer. Soochow: Soochow University Press.[8] Xu, H., Chen, X., Tao, M., et al. (2016) . B7-H3 and B7-H4 Are Independent Predictors of a Poor Prognosis in Patients with Pancreatic Cancer. Oncology Letters, 11(3).[9] Zhao, X., Li, D., Zhu, X., et al. (2013). B7-H3 Over-expression in Pancreatic Cancer Promotes Tumor Progression. Int J Mol Med, 31(2):283-91.[10]Zhao X. (2013). The Role and Mechanism of a Novel Costimulatory Molecule B7-H3 in the Malignant Progression of Pancreatic Cancer. Thesis of Soochow University, 8: 132.[11]Du, H., Hirabayashi, K., Ahn, S., et al. (2019). Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells. Cancer Cell, 35(2):221-37.[12]Nebbia, M., Sharazad, A., Deshpande, V., et al. (2022). Serum B7-H3 as a Novel Prognostic Biomarker for Patients with Pancreatic Adenocarcinoma. HPB, 24(S1).[13]Xu J, Huang B, Xiong P, et al..(2006). Soluble Mouse B7-H3 Down-regulates Dendritic Cell Stimulatory Capacity to Allogenic T Cell Proliferation and Production of IL-2 and IFN-gamma. Cell Mol Immunol. Jun; 3(3):235-40. [14]Zhao, X. (2013) .The Role and Mechanism of a Novel Costimulatory Molecule B7-H3 in the Malignant Progression of Pancreatic Cancer. Soochow University Press, Soochow.[15]Si, K., Xu, H., Ye, Z., et al. (2022). Antitumor Response of Anti-B7-H3 CAR-T Cells with Humanized scFv in Solid Tumors. Wuhan University Journal of Natural Sciences, 27(02):177-84.[16]Johnson, L., Lee, D., Eacret, J., et al. (2021) .The Immunostimulatory RNA RN7SL1 Enables CAR-T Cells to Enhance Autonomous and Endogenous Immune Function. Cell, 184(19):4981-95.